These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27416917)

  • 21. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations.
    Chen J; Korfmacher WA; Hsieh Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):1-8. PubMed ID: 15866486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulated bioanalysis of oligonucleotide therapeutics and biomarkers: qPCR versus chromatographic assays.
    Wang L; Meng M; Reuschel S
    Bioanalysis; 2013 Nov; 5(22):2747-51. PubMed ID: 24256356
    [No Abstract]   [Full Text] [Related]  

  • 24. High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.
    Barbara JE; Castro-Perez JM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3029-40. PubMed ID: 21953957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery.
    Saurina J; Sentellas S
    Expert Opin Drug Discov; 2019 May; 14(5):469-483. PubMed ID: 30810397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS.
    Xie C; Zhong D; Yu K; Chen X
    Bioanalysis; 2012 May; 4(8):937-59. PubMed ID: 22533568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted quantitative bioanalysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes.
    Xia YQ; Lau J; Olah T; Jemal M
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2863-78. PubMed ID: 21913265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.
    Buse J; Purves RW; Verrall RE; Badea I; Zhang H; Mulligan CC; Peru KM; Bailey J; Headley JV; El-Aneed A
    J Mass Spectrom; 2014 Nov; 49(11):1171-80. PubMed ID: 25395133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
    Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
    Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preface. Analytical chemistry for ADMET research: Recent advances and future directions in LC-MS/MS and omics approaches.
    Yoshinari K; Yamashita K
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):1-2. PubMed ID: 26852145
    [No Abstract]   [Full Text] [Related]  

  • 32. High-resolution mass spectrometry method for the detection, characterization and quantitation of pharmaceuticals in water.
    Pinhancos R; Maass S; Ramanathan DM
    J Mass Spectrom; 2011 Nov; 46(11):1175-81. PubMed ID: 22124990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new phase of drug discovery? The rise of PK/PD means extremely challenging work at the coalface.
    Smith DA
    Bioanalysis; 2015; 7(12):1415-7. PubMed ID: 26168248
    [No Abstract]   [Full Text] [Related]  

  • 34. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.
    Oliveira EJ; Watson DG
    Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel strategies for microdose studies using non-radiolabeled compounds.
    Maeda K; Sugiyama Y
    Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass spectrometry in drug metabolism and pharmacokinetics: Current trends and future perspectives.
    Cuyckens F
    Rapid Commun Mass Spectrom; 2019 Jul; 33 Suppl 3():90-95. PubMed ID: 30019507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A strategy to reduce biliary clearance in early drug discovery.
    Rioux N; Bellavance E; Poirier H; Dupuis M; Garneau M; Ribadeneira MD; Duan J
    J Pharmacol Toxicol Methods; 2013; 68(3):346-8. PubMed ID: 23518065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 40. Introduction of a routine quan/qual approach into research DMPK: experiences and evolving strategies.
    King L; Kotian A; Jairaj M
    Bioanalysis; 2014; 6(24):3337-48. PubMed ID: 25534790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.